RIG
HRMY icon

Roosevelt Investment Group’s Harmony Biosciences HRMY Stock Holding History

Roosevelt Investment Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$8.6M Buy
+194,084
New +$9.47M 0.62% 48

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Roosevelt Investment Group's HRMY Position: Q3 2022 in Review

Roosevelt Investment Group opened a new position in Harmony Biosciences (HRMY) in Q3 2022: 194,084 shares worth $8.6M. The stake represents 0.62% of the portfolio and ranks #48 among its holdings.

203 funds tracked by Wall St. Rank hold HRMY as of Q3 2022.

  • Roosevelt Investment Group held 194,084 shares of Harmony Biosciences worth $8.6M as of Q3 2022.
  • Harmony Biosciences was a new Roosevelt Investment Group position in Q3 2022.
  • Harmony Biosciences made up 0.62% of Roosevelt Investment Group's portfolio in Q3 2022, its #48 holding.
  • 203 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2022.

Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.